Condensed Interim Consolidated Statements of Net and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Profit or loss [abstract] | ||||
| Revenues | $ 10,093 | $ 10,000 | ||
| Expenses | ||||
| Research and development | 10,586 | 2,266 | 27,150 | 2,434 |
| General and administrative | 3,375 | 2,219 | 10,442 | 6,277 |
| Depreciation and amortization | 168 | 39 | 403 | 89 |
| Total expenses | 14,129 | 4,524 | 37,995 | 8,800 |
| Net (loss) income from operations | (14,129) | (4,524) | (27,902) | 1,200 |
| Finance income | (20) | (11) | (53) | (18) |
| (Gain) loss on fair value of warrant | (5,554) | (2,872) | (3,560) | 4,794 |
| Warrant derivative issue cost | 1,816 | |||
| Gain on settlement | (1,840) | |||
| Finance Income (Cost) | (5,574) | (2,883) | (3,613) | 4,752 |
| Net and comprehensive loss | $ (8,555) | $ (1,641) | $ (24,289) | $ (3,552) |
| Basic and diluted loss per share | $ (0.08) | $ (0.02) | $ (0.23) | $ (0.06) |
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of income or cost associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The gain on settlements of litigation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense relating to general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Basic and diluted income (loss) per share. No definition available.
|
| X | ||||||||||
- Definition Finance income (expense). No definition available.
|
| X | ||||||||||
- Definition Gain loss on change of fair value of warrant liability. No definition available.
|
| X | ||||||||||
- Definition Warrant liability issue cost. No definition available.
|